Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico evaluation of Vitis amurensis Rupr. Polyphenol compounds for their inhibition potency against COVID-19 main enzymes Mpro and RdRp. | Saudi Pharm J | 2022 | 35250347 | PubTator, text mining | PubMed |
| The importance of miRNA-630 in human diseases with an especial focus on cancers. | Cancer Cell Int | 2022 | 35248081 | PubTator, text mining | PubMed |
| Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair. | Sci Transl Med | 2022 | 35235339 | PubTator, text mining | PubMed |
| Tadr is an axonal histidine transporter required for visual neurotransmission in Drosophila. | Elife | 2022 | 35229720 | PubTator, text mining | PubMed |
| The Mechanotransduction Channel and Organic Cation Transporter Are Critical for Cisplatin Ototoxicity in Murine Hair Cells. | Front Mol Neurosci | 2022 | 35221917 | PubTator, text mining | PubMed |
| Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application. | Int J Mol Sci | 2022 | 35216167 | PubTator, text mining | PubMed |
| Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1. | Int J Mol Sci | 2022 | 35216120 | PubTator, text mining | PubMed |
| Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds. | Pharmaceuticals (Basel) | 2022 | 35215367 | PubTator, text mining | PubMed |
| Exploring the Natural Compounds in Flavonoids for Their Potential Inhibition of Cancer Therapeutic Target MEK1 Using Computational Methods. | Pharmaceuticals (Basel) | 2022 | 35215307 | PubTator, text mining | PubMed |
| Metabolic Impact of Anticancer Drugs Pd2Spermine and Cisplatin on the Brain of Healthy Mice. | Pharmaceutics | 2022 | 35213994 | PubTator, text mining | PubMed |
| Phytochemical and In Silico ADME/Tox Analysis of Eruca sativa Extract with Antioxidant, Antibacterial and Anticancer Potential against Caco-2 and HCT-116 Colorectal Carcinoma Cell Lines. | Molecules | 2022 | 35209197 | PubTator, text mining | PubMed |
| Protective Effect of Quercetin 3-O-Glucuronide against Cisplatin Cytotoxicity in Renal Tubular Cells. | Molecules | 2022 | 35209106 | PubTator, text mining | PubMed |
| Influence of Dialysis Membranes on Clinical Outcomes: From History to Innovation. | Membranes (Basel) | 2022 | 35207074 | PubTator, text mining | PubMed |
| The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells. | Cells | 2022 | 35203286 | PubTator, text mining | PubMed |
| Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine (mIBG). | Drug Metab Dispos | 2022 | 35197314 | PubTator, text mining | PubMed |
| Modeling oxidative injury response in human kidney organoids. | Stem Cell Res Ther | 2022 | 35189973 | PubTator, text mining | PubMed |
| DevKidCC allows for robust classification and direct comparisons of kidney organoid datasets. | Genome Med | 2022 | 35189942 | PubTator, text mining | PubMed |
| Tamsulosin alters the pharmacokinetics of metformin via inhibition of renal multidrug and toxin extrusion protein 1 and organic cation transporter 2 in rats. | J Pharm Biomed Anal | 2022 | 35183887 | PubTator, text mining | PubMed |
| Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice. | Transl Oncol | 2022 | 35182957 | PubTator, text mining | PubMed |
| Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population. | PLoS One | 2022 | 35176049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=30